Corcept Therapeutics Competitors and Similar CompaniesClear all

Corcept Therapeutics's competitors and similar companies include Baylor Scott & White Research Institute, ASLAN Pharmaceuticals, BeyondSpring and Telix Pharmaceuticals.
Corcept Therapeutics
Corcept Therapeutics
Corcept Therapeutics is a pharmaceutical company which discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders.
Baylor Scott & White Research Institute
Baylor Scott & White Research Institute
Baylor Scott & White Research Institute (BSWRI) is a research and development organization that studies population health, discovers new therapies, and conducts clinical trials.
ASLAN Pharmaceuticals
ASLAN Pharmaceuticals
ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.
BeyondSpring
BeyondSpring
BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.
Telix Pharmaceuticals
Telix Pharmaceuticals
Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care.
Founding Date
Founding Date
1998
Founding Date
1903
Founding Date
N/A
Founding Date
2010
Founding Date
2015
Type
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Menlo Park, US HQ
Locations
Dallas, US HQ
Locations
SG HQ
Collingwood, AU
Locations
Florham Park, US HQ
Locations
North Melbourne, AU HQ
Milton, AU
Sydney, AU
Herstal, BE
Burnaby, CA
Kyoto, JP
Lancy, CH
see more
Employees
Employees
20624% increase
Employees
600
Employees
353% increase
Employees
6712% decrease
Employees
41577% increase
Valuation ($)
Valuation ($)
3.3 b
Valuation ($)
N/A
Valuation ($)
7.2 m
Valuation ($)
94.3 m
Valuation ($)
4.6 b
Twitter followers
Twitter followers
192
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
454
Twitter followers
1.3 k

Financial

Revenue (est.)
Revenue (est.)
$482.4m (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
$12m (FY, 2023)
Revenue (est.)
$1.4m (FY, 2022)
Revenue (est.)
$502.5m (FY, 2023)
Cost of goods
Cost of goods
$6.5m (FY, 2023)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$181.4m (FY, 2023)
Gross profit
Gross profit
$475.9m (FY, 2023)
Gross profit
N/A
Gross profit
$12m (FY, 2023)
Gross profit
N/A
Gross profit
$321.3m (FY, 2023)
Net income
Net income
$106.1m (FY, 2023)
Net income
N/A
Net income
($44.2m) (FY, 2023)
Net income
($36.3m) (FY, 2022)
Net income
$5.2m (FY, 2023)

Funding

Total funding raised
Total funding raised
$ 80.1m
Total funding raised
N/A
Total funding raised
$ 100m
Total funding raised
$ 36.1m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Baylor Scott & White Research Institute
HQ
Dallas, US

Baylor Scott & White Research Institute (BSWRI) is a research and development organization that studies population health, discovers new therapies, and conducts clinical trials.

View company
ASLAN Pharmaceuticals
HQ
SG
Employees
35↑ 3% increase

ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.

View company
BeyondSpring
HQ
Florham Park, US
Employees
67↓ 12% decrease

BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.

View company
Telix Pharmaceuticals
HQ
North Melbourne, AU
Employees
415

Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care.

View company